Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
HC

Heather R. Coate — 32 Patents

Johnson & Johnson: 20 patents #432 of 7,810Top 6%
OPOsi Pharmaceuticals: 9 patents #18 of 181Top 10%
APAmira Pharmaceuticals: 3 patents #13 of 27Top 50%
San Diego, CA: #1,202 of 23,606 inventorsTop 6%
California: #15,919 of 386,348 inventorsTop 5%
Overall (All Time): #110,428 of 4,157,543Top 3%
32 Patents All Time
Heather R. Coate has been granted 32 US patents while listed as an inventor at Johnson & Johnson. The first was granted in 2010 and the most recent in March 2025. Heather R. Coate ranks #110,428 of 4,157,543 US inventors in our database (top 2.7%). Patent records list Heather R. Coate in San Diego, CA, US.

Patents per Year

Patents granted per year, 2010 to 2025Bar chart with a peak of 5 patents in 2017.peak 52010: 2 patents20102011: 2 patents2012: 3 patents20122014: 3 patents2015: 3 patents20152016: 2 patents2017: 5 patents20172018: 3 patents2019: 1 patents20192020: 2 patents2022: 3 patents20222023: 1 patents2024: 1 patents20242025: 1 patents2025

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12247027 P2X7 modulators Manuel Jesus Alcazar Vaca, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis, Curt A. Dvorak +6 more 2025-03-11
11993587 Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulators Curt A. Dvorak 2024-05-28 $258,476,000
11820770 P2X7 modulators Manuel Jesus Alcazar Vaca, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis, Curt A. Dvorak +6 more 2023-11-21 $91,340,000
11447503 Pyridine carbamates and their use as GLUN2B receptor modulators Christine F. Gelin, Brice M. Stenne, Curt A. Dvorak 2022-09-20 $224,601,000
11225478 P2X7 modulators Manuel Jesus Alcazar Vaca, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis, Curt A. Dvorak +6 more 2022-01-18 $218,672,000
11214563 Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulators Curt A. Dvorak 2022-01-04 $152,239,000
10766880 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators Gang Chen, Christa C. Chrovian, Curt A. Dvorak, Christine F. Gelin, Afton Hiscox +6 more 2020-09-08 $121,118,000
10703749 P2X7 modulators Manuel Jesus Alcazar Vaca, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis, Curt A. Dvorak +6 more 2020-07-07 $202,645,000
10233173 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators Gang Chen, Christa C. Chrovian, Curt A. Dvorak, Christine F. Gelin, Afton Hiscox +6 more 2019-03-19 $138,784,000
10150765 P2X7 modulators Manuel Jesus Alcazar Vaca, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis, Curt A. Dvorak +6 more 2018-12-11 $104,760,000
10112937 P2X7 modulators and methods of use Manuel Jesus Alcazar Vaca, Brett D. Allison, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis +12 more 2018-10-30 $110,785,000
10071988 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators Gang Chen, Christa C. Chrovian, Curt A. Dvorak, Christine F. Gelin, Afton Hiscox +6 more 2018-09-11 $121,919,000
9695183 Substituted 7-azabicycles and their use as orexin receptor modulators Curt A. Dvorak, Terry P. Lebold, Cathy Preville, Brock T. Shireman 2017-07-04
9637496 Substituted 7-azabicycles and their use as orexin receptor modulators Curt A. Dvorak, Anne E. Fitzgerald, Terry P. Lebold, Cathy Preville, Brock T. Shireman 2017-05-02 $67,428,000
9624182 Compounds as lysophosphatidic acid receptor antagonists Thomas Jon Seiders, Lucy Zhao, Jeannie M. Arruda, Bowei Wang, Brian Andrew Stearns +6 more 2017-04-18
9611251 Substituted piperidine compounds and their use as orexin receptor modulators Curt A. Dvorak, Cathy Preville, Brock T. Shireman 2017-04-04 $61,751,000
9611262 Substituted 2-azabicycles and their use as orexin receptor modulators Brock T. Shireman, Terry P. Lebold, Curt A. Dvorak, Jeannie M. Ziff, Cathy Preville +2 more 2017-04-04 $61,751,000
9475819 Substituted 7-azabicycles and their use as orexin receptor modulators Curt A. Dvorak, Terry P. Lebold, Cathy Preville, Brock T. Shireman 2016-10-25 $106,195,000
9464084 P2X7 modulators Manuel Jesus Alcazar Vaca, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis, Curt A. Dvorak +6 more 2016-10-11 $160,293,000
9090573 Compounds as lysophosphatidic acid receptor antagonists Thomas Jon Seiders, Lucy Zhao, Jeannie M. Arruda, Bowei Wang, Brian Andrew Stearns +6 more 2015-07-28
9066946 P2X7 modulators Manuel Jesus Alcazar Vaca, Jose Ignacio Andres Gil, Christa C. Chrovian, Meri De Angelis, Curt A. Dvorak +6 more 2015-06-30 $80,032,000
9062078 Substituted 7-azabicyles and their use as orexin receptor modulators Curt A. Dvorak, Terry P. Lebold, Cathy Preville, Brock T. Shireman 2015-06-23 $67,203,000
8796455 Fused bicyclic mTOR inhibitors Xin Chen, Andrew Philip Crew, Han-Qing Dong, Ayako Honda, Mark J. Mulvihill +12 more 2014-08-05
8735405 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Lee D. Arnold, Cara Cesario, Andrew Philip Crew, Hanqing Dong, Kenneth Foreman +13 more 2014-05-27
8664220 Polycyclic compounds as lysophosphatidic acid receptor antagonists Ryan C. Clark, Brian Andrew Stearns, Jill Melissa Scott, Lucy Zhao, Thomas Jon Seiders +5 more 2014-03-04